Terms: = Skin cancer AND AFP, AFPD, FETA, HPAFP AND Treatment
28 results:
1. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.
Camera S; Rimini M; Rossari F; Tada T; Suda G; Shimose S; Kudo M; Yoo C; Cheon J; Finkelmeier F; Lim HY; Presa J; Masi G; Bergamo F; Salani F; Marseglia M; Amadeo E; Vitiello F; Kumada T; Sakamoto N; Iwamoto H; Aoki T; Chon HJ; Himmelsbach V; Iavarone M; Cabibbo G; Montes M; Foschi FG; Vivaldi C; Lonardi S; Sho T; Niizeki T; Nishida N; Steup C; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Hatanaka T; Kakizaki S; Shimada N; Kawata K; Hiraoka A; Tada F; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Imai M; Kosaka H; Naganuma A; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Persano M; Foti S; Piscaglia F; Scartozzi M; Cascinu S; Casadei-Gardini A
Target Oncol; 2024 Jan; 19(1):29-39. PubMed ID: 38252195
[TBL] [Abstract] [Full Text] [Related]
2. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
Wen S; Zeng J; Zhong L; Ye J; Lai X
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy of TACE+Radiofrequency Ablation+Sorafenib in the treatment of Patients with Recurrent Liver cancer and Construction of Prediction Model.
Sun A; Chen S; Lin M; Zhou D; Zhang H; Sun C; Wang P
Comput Math Methods Med; 2022; 2022():6879035. PubMed ID: 36118840
[TBL] [Abstract] [Full Text] [Related]
4. Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Hsu PY; Cheng TS; Chuang SC; Chang WT; Liang PC; Hsu CT; Wei YJ; Jang TY; Yeh ML; Huang CI; Lin YH; Wang CW; Hsieh MY; Hou NJ; Hsieh MH; Tsai YS; Ko YM; Lin CC; Chen KY; Dai CY; Lin ZY; Chen SC; Huang JF; Chuang WL; Huang CF; Yu ML
Cancer Med; 2022 Jan; 11(1):104-116. PubMed ID: 34786871
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis.
Li D; Pang Y; Xu L; Xu X
J BUON; 2021; 26(4):1355-1364. PubMed ID: 34564992
[TBL] [Abstract] [Full Text] [Related]
6. Giant congenital nodular melanoma in a newborn: a case report and literature review.
Zhou J; Lv MX; Duan L; Xie YC; A ZX; Wu HF; Gao Y
BMC Pediatr; 2021 Mar; 21(1):121. PubMed ID: 33706747
[TBL] [Abstract] [Full Text] [Related]
7. Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome.
Liu W; Xu H; Ying X; Zhang D; Lai L; Wang L; Tu J; Ji J
Med Sci Monit; 2020 Jul; 26():e923263. PubMed ID: 32667906
[TBL] [Abstract] [Full Text] [Related]
8. Propranolol for infantile hepatic hemangioendothelioma: Clinical evaluation of drug efficacy and safety using a single-center patient cohort.
Tian R; Liang Y; Wang J; Shan Y; Gao H; Zhang L; Xie C; Li J; Xu M; Gu S
Ann Hepatol; 2020; 19(5):530-534. PubMed ID: 32532590
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract] [Full Text] [Related]
10. [Sustained Complete Response of Hepatocellular Carcinoma with Multiple Intrahepatic Metastases following the Discontinuation of Sorafenib].
Takeda Y; Ohmura Y; Katsura Y; Sakamoto T; Nose Y; Mori R; Inatome J; Kawai K; Naito A; Murakami K; Kagawa Y; Masuzawa T; Takeno A; Egawa C; Murata K
Gan To Kagaku Ryoho; 2019 Mar; 46(3):532-536. PubMed ID: 30914605
[TBL] [Abstract] [Full Text] [Related]
11. Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis.
Hiraoka A; Kumada T; Kariyama K; Takaguchi K; Atsukawa M; Itobayashi E; Tsuji K; Tajiri K; Hirooka M; Shimada N; Shibata H; Ishikawa T; Ochi H; Tada T; Toyoda H; Nouso K; Tsutsui A; Itokawa N; Imai M; Joko K; Hiasa Y; Michitaka K;
Cancer Med; 2019 Jan; 8(1):137-146. PubMed ID: 30575325
[TBL] [Abstract] [Full Text] [Related]
12. Impact of baseline characteristics on outcomes of advanced HCC patients treated with sorafenib: a secondary analysis of a phase III study.
Abdel-Rahman O
J Cancer Res Clin Oncol; 2018 May; 144(5):901-908. PubMed ID: 29455421
[TBL] [Abstract] [Full Text] [Related]
13. Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma.
Di Costanzo GG; Casadei Gardini A; Marisi G; Foschi FG; Scartozzi M; Granata R; Faloppi L; Cascinu S; Silvestris N; Brunetti O; Palmieri VO; Ercolani G; Tortora R
Target Oncol; 2017 Dec; 12(6):795-803. PubMed ID: 28770532
[TBL] [Abstract] [Full Text] [Related]
14. Giant Epignathus Teratoma Discovered at Birth: A Case Report and 7-Year Follow-Up.
Carvalho CHP; Nonaka CFW; Elias CTV; Matheus RCS; Dias RMB; Souza LB; Pinto LP
Braz Dent J; 2017; 28(2):256-261. PubMed ID: 28492758
[TBL] [Abstract] [Full Text] [Related]
15. Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Saito T; Motoyama T; Suzuki E; Tawada A; Kanai F; Yokosuka O
Invest New Drugs; 2015 Jun; 33(3):729-39. PubMed ID: 25861764
[TBL] [Abstract] [Full Text] [Related]
16. Unusual presentation of sacrococcygeal teratomas and associated malformations in children: clinical experience and review of the literature.
Paradies G; Zullino F; Orofino A; Leggio S
Ann Ital Chir; 2013; 84(3):333-46. PubMed ID: 23160138
[TBL] [Abstract] [Full Text] [Related]
17. Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review.
Zhang X; Yang XR; Huang XW; Wang WM; Shi RY; Xu Y; Wang Z; Qiu SJ; Fan J; Zhou J
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):458-66. PubMed ID: 23060390
[TBL] [Abstract] [Full Text] [Related]
18. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.
Xu G; Luo G; He L; Li J; Shan H; Zhang R; Li Y; Gao X; Lin S; Wang G
Ultrasound Med Biol; 2011 Dec; 37(12):1993-9. PubMed ID: 22036638
[TBL] [Abstract] [Full Text] [Related]
19. Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma.
Hsieh CH; Jeng KS; Lin CC; Chen CK; Liu CY; Lin CP; Tai HC; Wang CH; Shueng PW; Chen YJ
Clin Drug Investig; 2009; 29(1):65-71. PubMed ID: 19067476
[TBL] [Abstract] [Full Text] [Related]
20. Activity of thalidomide in patients with platinum-refractory germ-cell tumours.
Rick O; Braun T; Siegert W; Beyer J
Eur J Cancer; 2006 Aug; 42(12):1775-9. PubMed ID: 16765039
[TBL] [Abstract] [Full Text] [Related]
[Next]
